Comparison of hemodynamic changes (cardiac output, renal plasma flow, and extremity blood flow) observed during reserpine-induced hypotension with those occurring during pentoliniuminduced hypotension suggests better adaptation following reserpine. This difference is believed to be related to the gradation of onset of hypotension. It was found that reserpine-induced hypotension is potentiated by norepinephrine, and pentolinium-induced hypotension by serotonin. Pretreatment with the hypotensive agent increased the pressor response to norepinephrine and serotonin respectively, if the pressor substance was administered before the onset of hypotension.
T HE mechanism of action of pressor and depressor substances and their interrelationship have been of considerable interest to all workers concerned with the study of hypertensive disease. In this paper some studies are reported concerning relationships between reserpine (Serpasil), pentoliniuin (Ansolysen), norepinephrine, and serotonin. First, responses to 2 different hypotensive agents, namely pentolinium tartrate (Ansolysen) and reserpine (Serpasil) were compared with each other and correlated with the clinical behavior of the subjects in whom hypotension was induced. Then pressure responses to serotonin were studied. Finally, the behavior of pressure responses to norepinephrine and serotonin were ascertained after pretreatment with each of the 2 hypotensive agents, pentolinium and reserpine, before and after the hypotensive effect had become manifest.
METHODS AND MATERIAL
The response of hypertensive and normotensive This work was aided by a grant from the National Heart Institute, National Institutes of Health, Bethesda, Md.
Drs. Tangco and Lewis are fellows of the New YQrk Heart Association. subjects was studied in 74 experiments. Physiologic measurements of peripheral vascular beds were done by venous occlusion plethysmography, by means of apparatus previously described.' Plasma flow through a visceral (renal) vascular bed was measured with the para-aminohippurate infusion method.' Cardiac output was estimated from an arterial dilution curve after rapid injection of Na" by the method described by Powers,3 with minor modifications. Whenever these measurements were carried out, the subject was tested under basal conditions in a constant temperature room at 20 C. and 55 per cent humidity, as described previously.4 Whenever only the responses of arterial pressure, heart rate, and clinical behavior were ascertained, the experiments were performed under ward conditions. Three drugs were given in single intravenous doses: reserpine (Serpasil) 3 nmg-., pentolinium, (Ansolysen) 3.5 mg., serotonin 2.5 mg. Norepinephrine was used in a solution of 4 mg. in 1000 ml. of 5 per cent glucose in water at an infusion rate of 20 drops per minute. The hypotensive response to reserpine was regularly associated with an early short-lasting increase in blood flow to the lower extremities, an equally brief but delayed increase in renal plasma flow, and no measurable change in cardiac output. The pulse rate remained unchanged or was slightly increased ( fig. 1 ). In contrast is the hypotension following ganglionic blocking, which is associated with diminished cardiac output, a marked increase in blood flow to the extremities, and marked decrease in renal plasma flow. The known side effects associated with the precipitous fall in arterial pressure after administration of ganglionic-blocking agents are noticeably absent after reserpine. There was no postural hypotension or other clinical side effects, except mild flushing. Infusion of norepinephrine restored promptly the levels of both systolic and diastolic arterial pressure lowered by reserpine. When norepinephrine was infused after the hypotensive action of reserpine had set in (9 experiments) there was immediate rise in pressure. When the infusion was discontinued, pressures returned to the former hypotensive levels produced by reserpine and then dropped to even lower levels that were maintained for many hours ( fig. 2) .
RESULTS

Single
Recently, attention has been focused on 5-hydroxy-tryptamine, commonly called serotonin. This substance, as Brodie and his coworkers5 have shown, has a peculiar relationship to reserpine. It is stored predominantly in intestines, brain, and platelets and, when released into the blood stream, it is rapidly destroyed by amine oxidase. Reserpine causes depletion of serotonin depots that outlasts the presence of reserpine in the serum. This point is of particular interest, because the hypotensive effect of a single dose of reserpine also outlasts the presence of the drug in the serum. 6 Serotonin, in doses of 2.5 mg., was administered intravenously in 14 experiments and was found regularly to increase both systolic and diastolic pressures. The rise was immediate (within 2 to 10 minutes) followed by a short-lasting drop in both levels of pressure ( fig. 3) 
